Sacubitril-Valsartan versus Standard Anti -Hypertensives in Left Ventricular Assist Device Patients

被引：1
|
作者：
Nicolsen, Erika [1 ]
Curran, Lisa [1 ]
Dixon, Stephanie [1 ]
Reece, Molly [1 ]
Herbert, Sarah [1 ]
Clegg, Amy [1 ]
Tillery, Michael [1 ]
Bensimhon, Daniel [1 ]
McLean, Dalton [1 ]
机构：
[1] Cone Hlth, Greensboro, NC USA
来源：
JOURNAL OF CARDIAC FAILURE | 2018年 / 24卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2018.07.086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
070
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [41] Eligibility for sacubitril-valsartan in patients with acute decompensated heart failure
    Carballo, David
    Stirnemann, Jerome
    Garin, Nicolas
    Marti, Chistophe
    Serratrice, Jacques
    Carballo, Sebastian
    ESC HEART FAILURE, 2020, 7 (03): : 1282 - 1290
  • [42] LEWhat proportion of patients with HFrEF might be candidates for Sacubitril-Valsartan?
    Lopez, M. Montoro
    O'connor, T.
    Ibrahim, T.
    Sweeney, E.
    Bakcsi, F.
    Islam, M.
    Stakelum, N.
    Carter, N.
    Gray, C.
    Halley, C.
    Keelan, P.
    Murphy, N. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 201 - 201
  • [43] Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction
    Vergaro, Giuseppe
    Del Franco, Annamaria
    Carecci, Alessandro
    Chen, Yu Fu Ferrari
    Aimo, Alberto
    Forini, Francesca
    Nicolini, Giuseppina
    Kusmic, Claudia
    Faita, Francesco
    Castiglione, Vincenzo
    De Tata, Vincenzo
    Pucci, Angela
    Musetti, Veronica
    Burchielli, Silvia
    Passino, Claudio
    Emdin, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 409
  • [44] Dapagliflozin Versus Sacubitril-Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus
    Hammerman, Ariel
    Azuri, Joseph
    Aboalhasan, Enis
    Arbel, Ronen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 325 - 331
  • [45] Effect of 1-year sacubitril-valsartan treatment on myocardial deformation and left ventricular ejection fraction in patients with congestive heart failure
    Laterra, Giulia
    Vaccaro, Vittoria
    Morabito, Claudia
    Bitto, Roberto
    Di Bella, Gianluca
    Crea, Pasquale
    Costantino, Rossella
    Dattilo, Giuseppe
    De Gregorio, Cesare
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0J) : J126 - J126
  • [46] Left ventricular reverse remodelling after sacubitril - valsartan
    Galvan Ruiz, M.
    De Sanmamed Giron, M. Fernandez
    Singh, M.
    Groba Marco, M. V.
    Davila Ramos, M.
    Quevedo Nelson, V.
    Blanco Nuez, M.
    Pena Ortega, P.
    Rua-Figueroa Erausquin, D.
    Medina Suarez, J. M.
    Bonilla Fernandez, J. A.
    Escobar Gonzalez, M.
    Suarez Perez, I.
    Caballero Dorta, E.
    Garcia Quintana, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 90 - 91
  • [47] Impact of sacubitril/valsartan on left ventricular ejection fraction in patients with heart failure
    Furlan, T.
    Leskovar, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 111 - 112
  • [48] Early left ventricular reverse remodeling after sacubitril-valsartan treatment. Subanalysis of SAVE-RLife study
    Galvan Ruiz, M.
    Singh, M.
    Sanmamed Giron, M.
    Groba Marco, M.
    Lopez Perez, M.
    Blanco Nuez, M.
    Quevedo Nelson, V.
    Pena Ortega, P.
    Medina Suarez, J.
    Rua-Figueroa Erausquin, D.
    Ortega Trujillo, J. R.
    Morales Gonzalez, J. R.
    Caballero Dorta, E.
    Garcia Quintana, A. Antonio
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 232 - 232
  • [49] Left ventricular assist device implantation in patients with left ventricular thrombus
    Dogan, Gunes
    Mariani, Silvia
    Hanke, Jasmin S.
    Deniz, Ezin
    Merzah, Ali
    Li, Tong
    Haverich, Axel
    Schmitto, Jan D.
    ARTIFICIAL ORGANS, 2021, 45 (09) : 1006 - 1013
  • [50] Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist
    DeVore, Adam D.
    Patel, Priyesh A.
    Patel, Chetan B.
    JACC-HEART FAILURE, 2017, 5 (09) : 621 - 631
12345